I. Vergote

D. Cella, I. Vergote, L. Wenzel, 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Upregulation of Wilms' tumour gene 1 (WT1) in uterine sarcomas.

F. Amant, A. Coosemans, G. Verbist, 2007, European journal of cancer.

Importance of the endometrioid carcinoma subtype and sarcomatous component in uterine carcinosarcoma.

F. Amant, I. Vergote, 2004, Gynecologic Oncology.

Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature.

A. Hagemeijer, M. Debiec‐Rychter, F. Amant, 2003, Gynecologic oncology.

Transition of epithelial toward mesenchymal differentiation during ovarian carcinosarcoma tumorigenesis.

F. Amant, P. Moerman, I. Vergote, 2003, Gynecologic oncology.

PTEN mutation analysis in uterine leiomyosarcomas and mixed mullerian sarcomas.

F. Amant, I. Vergote, 2002, American journal of obstetrics and gynecology.

Chronic Tumor Necrosis Factor-α Infusion in Gravid C57BL6/J Mice Accelerates Adipose Tissue Development in Female Offspring

J. Verhaeghe, I. Vergote, S. Lambin, 2006, The Journal of the Society for Gynecologic Investigation: JSGI.

Adipose tissue in offspring of Lepr(db/+) mice: early-life environment vs. genotype.

J. Verhaeghe, I. Vergote, L. Vercruysse, 2007, American journal of physiology. Endocrinology and metabolism.

VERSUS UPFRONT DEBULKING SURGERY IN ADVANCED TUBO-OVARIAN

G. Jayson, G. Kenter, M. Nankivell, 2018 .

Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome.

P. Neven, F. Amant, T. Van Gorp, 2007, American journal of obstetrics and gynecology.

Role of lymphadenectomy and pelvic radiotherapy in patients with clinical FIGO stage I endometrial adenocarcinoma: an analysis of 208 patients

E. van Limbergen, P. Neven, F. Amant, 2002, International Journal of Gynecologic Cancer.

NCOLOGY aparoscopy-assisted vaginal hysterectomy compared with bdominal hysterectomy in clinical stage I endometrial ancer : safety , recurrence , and long-term outcome

P. Neven, F. Amant, I. Vergote, 2022 .

Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer

P. Neven, D. Lambrechts, F. Amant, 2015, BMC Pharmacology and Toxicology.

A thin and regular endometrium on ultrasound is very unlikely in patients with endometrial malignancy

D. Timmerman, T. Van den Bosch, F. Amant, 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Chemotherapy for recurrent cervical cancer.

P. Neven, F. Amant, T. Van Gorp, 2007, Gynecologic oncology.

Chemotherapy for cervical cancer

F. Amant, I. Vergote, I. Cadron, 2005 .

Clinical Outcome of ET-743 (Trabectedin; Yondelis) in High-Grade Uterine Sarcomas: Report on Five Patients and a Review of the Literature

F. Amant, A. Coosemans, I. Vergote, 2009, International Journal of Gynecologic Cancer.

Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study.

H. Hollema, A. V. D. Van Der Zee, R. Verheijen, 2010, The Lancet. Oncology.

Understanding the problem of inadequately staging early ovarian cancer.

A. Zwinderman, J. Trimbos, I. Vergote, 2010, European journal of cancer.

Molecular profiling of platinum resistant ovarian cancer: Use of the model in clinical practice

N. Pochet, B. De Moor, D. Timmerman, 2006, International journal of cancer.

Role of Neoadjuvant Chemotherapy in the Management of Stage IIIC–IV Ovarian Cancer: Survey Results from the Members of the European Society of Gynecological Oncology

B. van Calster, F. Amant, K. Leunen, 2012, International Journal of Gynecologic Cancer.

Morcellation of uterine leiomyomas: a plea for patient triage.

D. Timmerman, T. Van den Bosch, F. Amant, 2015, The Lancet. Oncology.

Proteomic analysis of laser microdissected ovarian cancer tissue with SELDI-TOF MS.

P. Moerman, T. Van Gorp, E. Waelkens, 2011, Methods in molecular biology.

Effect of laparoscopic surgery for moderate and severe endometriosis on depression, relationship satisfaction and sexual functioning: comparison of patients with and without bowel resection.

A. Wolthuis, I. Vergote, C. Meuleman, 2013, Human reproduction.

Staging with Unilateral Salpingo-Oophorectomy and Expert Pathological Review Result in No Recurrences in a Series of 81 Intestinal-Type Mucinous Borderline Ovarian Tumors

P. Neven, F. Amant, P. Moerman, 2017, Gynecologic and Obstetric Investigation.

Novel polymerase chain reaction approach for full-coding p53 mutation detection in microdissected archival tumors.

I. Vergote, M. Davies, K. Joyce, 2000, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Cancer

P. Neven, F. Amant, K. Leunen, 2016 .

Use of PlasmaJet for Peritoneal Carcinomatosis in Ovarian Cancer

P. Neven, K. Leunen, I. Vergote, 2016, International Journal of Gynecologic Cancer.

Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?

F. Amant, K. Leunen, I. Vergote, 2010, Gynecologic oncology.

Lower-Limb Lymphedema after Sentinel Lymph Node Biopsy in Cervical Cancer Patients

S. Marnitz, C. Köhler, D. Cibula, 2021, Cancers.

2-methoxyestradiol strongly inhibits human uterine sarcomatous cell growth.

F. Amant, M. Lottering, A. Joubert, 2003, Gynecologic oncology.

Alizapride and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic gynaecological surgery: A double-blind, randomised, placebo-controlled noninferiority study

S. Fieuws, I. Vergote, C. Meuleman, 2016, European journal of anaesthesiology.

Diet-induced obesity in gravid rats engenders early hyperadiposity in the offspring.

J. Verhaeghe, I. Vergote, S. Lambin, 2007, Metabolism: clinical and experimental.

ETHNIC VARIATIONS IN UTERINE LEIOMYOMA BIOLOGY ARE NOT CAUSED BY DIFFERENCES IN MYOMETRIAL ESTROGEN RECEPTOR ALPHA LEVELS

F. Amant, E. Schoenmakers, A. Geurts-Moespot, 2003, International Journal of Gynecologic Cancer.

The Use of Lymph Vessel Markers to Predict Endometrial Cancer Outcome

F. Amant, B. Calster, G. Verbist, 2010, International Journal of Gynecologic Cancer.

Prophylactic salpingo-oophorectomy in 51 women with familial breast–ovarian cancer: importance of fallopian tube dysplasia

P. Neven, F. Amant, E. Legius, 2005, International Journal of Gynecologic Cancer.

Para-aortic lymph node metastases in locally advanced cervical cancer: Comparison between surgical staging and imaging.

E. van Limbergen, F. Amant, P. Moerman, 2015, Gynecologic oncology.

Dendritic cell immunotherapy in uterine cancer

F. Amant, A. Coosemans, S. V. Van Gool, 2014, Human vaccines & immunotherapeutics.

mRNA Electroporation of Dendritic Cells with WT1, Survivin, and TriMix (a Mixture of caTLR4, CD40L, and CD70).

F. Amant, A. Coosemans, S. V. Van Gool, 2016, Methods in molecular biology.

The role of neoadjuvant chemotherapy versus primary surgery in the management of stage III ovarian cancer.

P. Neven, F. Amant, T. Van Gorp, 2007, Cancer treatment and research.

Gemcitabine in Platin-Paclitaxel Resistant Ovarian Carcinoma

F. Amant, I. Vergote, M. Coenen, 2000 .

The Role of Adjuvant Chemotherapy in Surgical Stages I-II Serous and Clear Cell Carcinomas and Carcinosarcoma of the Endometrium: A Collaborative Study

P. Neven, F. Amant, J. Trovik, 2010, International Journal of Gynecologic Cancer.

Endometrial cancer: predictors of response and preferred endocrine therapy.

P. Neven, F. Amant, K. Leunen, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancer.

P. Neven, F. Amant, D. Tsolakidis, 2010, Gynecologic oncology.

Weekly Paclitaxel/Carboplatin in the Treatment of Locally Advanced, Recurrent, or Metastatic Vulvar Cancer

F. Amant, Sileny N. Han, I. Vergote, 2012, International Journal of Gynecologic Cancer.

Laparoscopic para‐ aortic lymphadenectomy and positron emission tomography scan as staging procedures in patients with cervical carcinoma stage IB2–IIIB

E. van Limbergen, P. Neven, F. Amant, 2008, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer

F. Amant, I. Vergote, M. van Gramberen, 2001, International Journal of Gynecologic Cancer.

Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer

F. Amant, I. Vergote, M. van Gramberen, 2002, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I.

D. Provencher, K. Gaarenstroom, V. Zanagnolo, 2016, Gynecologic oncology.

Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions

G. Kenter, F. Amant, K. Gaarenstroom, 2003, International Journal of Gynecologic Cancer.

Uterine sarcomas in South African black women: a clinicopathologic study with ethnic considerations.

F. Amant, I. Vergote, B. Lindeque, 2001, European journal of gynaecological oncology.

Primary invasive mucinous ovarian carcinoma of the intestinal type: importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases.

P. Neven, F. Amant, P. Moerman, 2013, European journal of cancer.

Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma.

F. Amant, Z. Berneman, A. Coosemans, 2013, Anticancer research.

Adjuvant therapy for postmenopausal ER-positive breast cancer. Why tamoxifen still has a future? The Leuven point of view.

P. Neven, R. Paridaens, M. Christiaens, 2006, International Journal of Gynecological Cancer.

Primary surgery or neoadjuvant chemotherapy in ovarian cancer: what is the value of comparing apples with oranges?

F. Amant, K. Leunen, I. Vergote, 2012, Gynecologic oncology.

A possible role of the cytochrome P450c17α gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot study

J. Vandewalle, F. Amant, I. Vergote, 2004, Acta obstetricia et gynecologica Scandinavica.

Endocrine treatment and prevention of breast and gynaecological cancers

P. Neven, P. Dam, W. Tjalma, 2002 .

Systematic study of tissue factor expression in solid tumors

I. Vergote, J. D. de Bono, R. Christova, 2022, Cancer reports.

The Role of Diaphragmatic Surgery During Interval Debulking After Neoadjuvant Chemotherapy: an Analysis of 74 Patients With Advanced Epithelial Ovarian Cancer

P. Neven, F. Amant, D. Tsolakidis, 2010, International Journal of Gynecologic Cancer.

In utero exposure to chemotherapy: effect on cardiac and neurologic outcome.

L. Lagae, P. Claus, R. Paridaens, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mitigation and management strategies for ocular events associated with tisotumab vedotin.

B. Monk, R. Coleman, I. Vergote, 2022, Gynecologic oncology.

Case report: An Ovarian Inflammatory Mass, Possibly Related to a Recent COVID-19 Infection

R. Dresen, C. Deroose, T. Tousseyn, 2021 .

Does Paclitaxel-Carboplatin Chemotherapy in a Dose-Dense Regimen Enhance Survival of BRCA-Related Ovarian Cancer Patients?

P. Neven, F. Amant, E. Legius, 2009, International Journal of Gynecologic Cancer.

Pseudomyxoma peritonei associated with a mucinous ovarian tumor arising from a mature cystic teratoma. A case report.

F. Amant, P. Moerman, I. Vergote, 2006, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells.

F. Amant, T. Van Gorp, A. Mihályi, 2010, Gynecologic oncology.

Role of diaphragmatic surgery in 69 patients with ovarian carcinoma

P. Neven, F. Amant, T. Van Gorp, 2007, International Journal of Gynecologic Cancer.

Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma

B. van Calster, P. Neven, S. Van Huffel, 2007, British Journal of Cancer.

Is there a role for neoadjuvant chemotherapy in the treatment of stage IV serous endometrial carcinoma?

F. Amant, P. Moerman, I. Vergote, 2005, International Journal of Gynecologic Cancer.

Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I.

D. Provencher, H. V. van Doorn, G. D. de Bock, 2016, Gynecologic oncology.

Consensus Statement on pre- operative diagnosis of ovarian tumors

T. Bourne, D. Timmerman, N. Concin, 2021 .

Kit Gene in Endometrial Carcinoma: An Immunohistochemical and Mutational Analysis

M. Debiec‐Rychter, F. Amant, G. Verbist, 2011, International Journal of Gynecologic Cancer.

Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors

P. Neven, F. Amant, P. Moerman, 2016, International Journal of Gynecologic Cancer.

Gynecologic Cancers in Pregnancy: Guidelines of a Second International Consensus Meeting

O. Mir, M. Lishner, M. Fumagalli, 2009, International Journal of Gynecologic Cancer.

Gynecologic Cancers in Pregnancy: Guidelines of an International Consensus Meeting

L. Lagae, J. Beijnen, F. Amant, 2009, International Journal of Gynecologic Cancer.

The addition of 4% oxygen to the CO(2) pneumoperitoneum does not decrease dramatically port site metastases.

F. Amant, P. Moerman, I. Vergote, 2008, Journal of minimally invasive gynecology.

Endometrial cancer.

Patrick Neven, Dirk Timmerman, Philippe Moerman, 2005, Lancet.

Importance of pathological review of gestational trophoblastic diseases: results of the Belgian Gestational Trophoblastic Diseases Registry

P. Delvenne, E. Marbaix, P. Moerman, 2022, International Journal of Gynecological Cancer.

Immunological configuration of ovarian carcinoma: features and impact on disease outcome

L. Galluzzi, S. Orsulic, A. Coosemans, 2021, Journal for ImmunoTherapy of Cancer.

EP-EMA Regimen (Etoposide and Cisplatin With Etoposide, Methotrexate, and Dactinomycin) in a Series of 18 Women With Gestational Trophoblastic Neoplasia

P. Neven, F. Amant, Sileny N. Han, 2012, International Journal of Gynecologic Cancer.

PTEN mutations in uterine sarcomas.

F. Amant, I. Vergote, E. J. van Rensburg, 2002, Gynecologic oncology.

Cumulative dosage effect of a RAD51l1/HMGA2 fusion and RAD51l1 loss in a case of pseudo‐Meigs' syndrome

M. Debiec‐Rychter, F. Amant, E. Schoenmakers, 2001, Genes, chromosomes & cancer.

Microsatellite instability in uterine sarcomas

F. Amant, I. Vergote, E. J. van Rensburg, 2001, International Journal of Gynecologic Cancer.

Evolution in Endometrial Cancer: Evidence From an Immunohistochemical Study

L. Akslen, F. Amant, J. Trovik, 2011, International Journal of Gynecologic Cancer.

Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies.

D. Lambrechts, F. Amant, D. Annibali, 2015, Gynecologic oncology.

Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer.

D. Lambrechts, R. Zeillinger, F. Amant, 2014, Gynecologic oncology.

Laparoscopic versus robotic-assisted sacrocolpopexy for pelvic organ prolapse: a systematic review

Jan Deprest, Ben Van Cleynenbreugel, Susanne Housmans, 2016, Gynecological Surgery.

ENDOMETRIAL STROMAL SARCOMA WITH A SOLE T(X;17) CHROMOSOME CHANGE

A. Hagemeijer, F. Amant, I. Vergote, 2003, International Journal of Gynecologic Cancer.

Endometrial carcinosarcoma

B. Monk, A. Mariani, S. Pignata, 2022, International Journal of Gynecological Cancer.

Sentinel node dissection is safe in the treatment of early-stage vulvar cancer.

Achim Schneider, A. V. D. Van Der Zee, A. Schneider, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mesonephric (Wolffian) Pseudoendometrioid Carcinoma of the Broad Ligament, Arising From a Papillary Cystadenoma

F. Amant, P. Moerman, I. Vergote, 2016, International journal of surgical pathology.

Second case of uterine mesonephric adenocarcinoma

F. Amant, P. Moerman, I. Vergote, 2005, International Journal of Gynecologic Cancer.

Gynecologic oncology in pregnancy.

F. Amant, I. Vergote, K. Van Calsteren, 2008, Critical reviews in oncology/hematology.

Effectiveness of weekly topotecan in patients with recurrent epithelial ovarian cancer

P. Neven, F. Amant, K. Leunen, 2006, International Journal of Gynecologic Cancer.

Gemcitabine–carboplatin–paclitaxel combination as first‐line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients

P. Neven, F. Amant, I. Vergote, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Endometrial carcinosarcoma with osteoclast-like giant cells.

F. Amant, P. Moerman, T. Van Gorp, 2006, European journal of gynaecological oncology.

The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned.

F. Amant, P. Moerman, I. Vergote, 2004, Gynecologic oncology.

THE DIAGNOSTIC PROBLEM OF ENDOMETRIAL STROMAL SARCOMA: REPORT ON SIX CASES

P. Neven, F. Amant, P. Moerman, 2003, International Journal of Gynecologic Cancer.

FIRST RESULTS OF A RANDOMISED TRIAL COMPARING RADIOTHERAPY VERSUS- OBSERVATION POST OPERATIVELY IN PATIENTS WITH UTERINE SARCOMAS. AN EORTC-GCG STUDY

A. Poveda, I. Vergote, C. Mangioni, 2003, International Journal of Gynecologic Cancer.

European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma

N. Concin, J. Sehouli, A. Fagotti, 2021, International Journal of Gynecological Cancer.

Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923).

H. Bonnefoi, I. Vergote, C. Coens, 2003, European journal of cancer.

Pitfall in the diagnosis of endometrial cancer: case report of an endometrioid adenocarcinoma arising from uterine adenomyosis.

D. Timmerman, F. Amant, P. Moerman, 2011, European journal of gynaecological oncology.

Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: an analysis of 163 patients.

P. Neven, F. Amant, D. Tsolakidis, 2011, European journal of cancer.

Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.

E. van Limbergen, P. Neven, P. Moerman, 2015, Gynecologic oncology.

Final Program

A. Daemen, L. Ameye, I. Vergote, 2019, 2019 China-Qatar International Workshop on Artificial Intelligence and Applications to Intelligent Manufacturing (AIAIM).

The diagnostic problem of endometrial stromal sarcoma

P. Neven, F. Amant, P. Moerman, 2002 .

European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer

F. Landoni, D. Cibula, C. Fotopoulou, 2020, International Journal of Gynecological Cancer.

Long-Term Sexual Functioning in Women After Surgical Treatment of Cervical Cancer Stages IA to IB: A Prospective Controlled Study

F. Amant, J. Verhaeghe, I. Vergote, 2014, International Journal of Gynecologic Cancer.

Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia

A. Whittemore, L. Kiemeney, K. Stefánsson, 2015, Nature Genetics.

Microsatellite Instable and Microsatellite Stable Primary Endometrial Carcinoma Cells and Their Subcutaneous and Orthotopic Xenografts Recapitulate the Characteristics of the Corresponding Primary Tumor

D. Lambrechts, F. Amant, G. Verbist, 2014, International Journal of Gynecologic Cancer.

Surgical treatment of deeply infiltrating endometriosis with colorectal involvement.

I. Vergote, C. Meuleman, C. Tomassetti, 2011, Human reproduction update.

Two-year prospective clinical outcome assessment after radical excision of moderate-severe endometriosis with or without bowel resection and reanastomosis

A. Wolthuis, A. Laenen, I. Vergote, 2011 .

Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer

P. Neven, D. Lambrechts, P. Moerman, 2019, Neoplasia.

Proceedings of the International Cancer Imaging Society (ICIS) 16th Annual Teaching Course

Jeong Min Lee, W. Oyen, J. Fütterer, 2016, Cancer Imaging.

Quality of Life Considerations in Gynecologic Cancer

D. Cella, I. Vergote, L. Wenzel, 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Endometrial cancer

Patrick Neven, Dirk Timmerman, Philippe Moerman, 2005, The Lancet.

Comprehensive immunomolecular profiling of endometrial carcinoma: A tertiary retrospective study.

H. Brems, A. Laenen, T. Van Gorp, 2021, Gynecologic oncology.

Tisotumab vedotin in recurrent or metastatic cervical cancer.

B. Monk, R. Coleman, G. Bogani, 2023, Current problems in cancer.

Best original research presented at the 23rd European Congress on Gynaecological Oncology—Best of ESGO 2022

J. Ledermann, A. Strojna, A. Pletnev, 2022, International Journal of Gynecological Cancer.

Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?

B. van Calster, P. Neven, F. Amant, 2009, British Journal of Cancer.

Treatment modalities in endometrial cancer

E. van Limbergen, D. Timmerman, P. Neven, 2007, Current opinion in oncology.

Genetic changes in nonepithelial ovarian cancer

D. Lambrechts, F. Amant, K. Leunen, 2013, Expert review of anticancer therapy.

Epithelial Ovarian Cancer: Rationale for Changing the One-Fits-All Standard Treatment Regimen to Subtype-Specific Treatment

E. Berns, D. Lambrechts, F. Amant, 2014, International Journal of Gynecologic Cancer.

Wilms' tumor gene 1 (WT1) in endometrial carcinoma.

P. Neven, F. Amant, A. Coosemans, 2008, Gynecologic oncology.

Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I–II Cervical Cancer

P. Neven, F. Amant, P. Moerman, 2017, International Journal of Gynecologic Cancer.

Wilms' Tumor Gene 1 (WT1)--loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial.

F. Amant, Z. Berneman, A. Coosemans, 2013, Anticancer research.

Wilms Tumor Gene 1 (WT1) is a Prognostic Marker in High-Grade Uterine Sarcoma

B. van Calster, F. Amant, A. Coosemans, 2010, International Journal of Gynecologic Cancer.

Bilateral Mammary Tuberculosis Associated with a Borderline Ovarian Tumor

P. Neven, F. Amant, A. Cornelis, 2008, Breast Care.

Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses.

B. van Calster, D. Timmerman, F. Amant, 2012, European journal of cancer.

Sexual, psychological, and relational functioning in women after surgical treatment for vulvar malignancy: a literature review.

F. Amant, J. Verhaeghe, I. Vergote, 2012, The journal of sexual medicine.

Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium

Theresia Thalhammer, Carsten Denkert, Georg Heinze, 2013, BMC Cancer.

Immunohistochemical expression of CD10 antigen in uterine adenosarcoma

V. Abeler, G. Tulunay, F. Amant, 2004, International Journal of Gynecologic Cancer.

Weekly Paclitaxel-Carboplatin Regimen in Patients With Primary Advanced or Recurrent Endometrial Carcinoma

P. Neven, F. Amant, I. Vergote, 2012, International Journal of Gynecologic Cancer.

PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer.

B. van Calster, D. Timmerman, P. Neven, 2013, Gynecologic oncology.

Uterine Carcinosarcoma With Melanocytic Differentiation

F. Amant, P. Moerman, I. Vergote, 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

External validation of non-imaging models for predicting distant metastasis in patients with endometrial cancer.

F. Amant, I. Vergote, M. Koskas, 2016, Gynecologic oncology.

Expression of ERCC1, p53, and Class III &bgr;-Tubulin Do Not Reveal Chemoresistance in Endometrial Cancer: Results From an Immunohistochemical Study

F. Amant, G. Verbist, P. Moerman, 2011, International Journal of Gynecologic Cancer.

Psychologic, Relational, and Sexual Functioning in Women After Surgical Treatment of Vulvar Malignancy: A Prospective Controlled Study

F. Amant, J. Verhaeghe, I. Vergote, 2014, International Journal of Gynecologic Cancer.

Randomised trial of drains versus no drains following radical hysterectomy and pelvic lymph node dissection: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG) study in 234 patients.

M. Franchi, I. Vergote, C. Coens, 2007, European journal of cancer.

Sexual and psychological functioning in women after pelvic surgery for gynaecological cancer.

F. Amant, J. Verhaeghe, I. Vergote, 2009, European journal of gynaecological oncology.

Peritoneal recurrences might be less common in advanced stage serous borderline ovarian tumors that were treated by laparotomy.

F. Amant, I. Vergote, I. Vandenput, 2005, Gynecologic oncology.

Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT

S. Dymarkowski, F. Amant, P. Moerman, 2014, European Radiology.

ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors

T. Bourne, D. Timmerman, N. Concin, 2021, International Journal of Gynecological Cancer.

Pseudo-Meigs' syndrome caused by a hydropic degenerating uterine leiomyoma with elevated CA 125.

D. Timmerman, F. Amant, I. Vergote, 2001, Gynecologic oncology.

HPV induced ovarian squamous cell carcinoma: case report and review of the literature

F. Amant, P. Moerman, I. Vergote, 2007, Archives of Gynecology and Obstetrics.

Sexual functioning in women after surgical treatment for endometrial cancer: a prospective controlled study.

F. Amant, J. Verhaeghe, I. Vergote, 2015, The journal of sexual medicine.

Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy.

P. Neven, F. Amant, K. Leunen, 2013, Gynecologic oncology.

Quality of life considerations in gynecologic cancer. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

D. Cella, I. Vergote, L. Wenzel, 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Positive peritoneal cytology following laparoscopic assisted vaginal hysterectomy for endometrial carcinoma

F. Amant, I. Vergote, I. Smet, 2002 .

Medical Fellowship Programme within the Gynaecological Cancer Group of the European Organisation for Research and Treatment of Cancer

P. Therasse, I. Vergote, I. Teodorović, 2004, Gynecologic and Obstetric Investigation.

Classification of radical hysterectomy adopted by the Gynecological Cancer Group of the European Organization for Research and Treatment of Cancer1

P. Zola, F. Amant, R. Verheijen, 2007, International Journal of Gynecologic Cancer.

Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer.

F. Amant, K. Leunen, I. Vergote, 2012, European journal of cancer.

Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer.

F. De Keyzer, F. Amant, R. Vanslembrouck, 2017, European journal of cancer.

Supervised Classification of Array CGH Data with HMM-Based Feature Selection

Bart De Moor, Olivier Gevaert, Anneleen Daemen, 2008, Pacific Symposium on Biocomputing.

Laparoscopic assisted vaginal hysterectomy (LAVH) in Stage I endometrial cancer does not increase the incidence of positive peritoneal cytology

F. Amant, I. Vergote, I. Smet, 2002 .

Wilms’ tumour gene 1 (WT1) positivity in endothelial cells surrounding epithelial uterine tumours

P. Neven, F. Amant, L. Moons, 2009, Histopathology.

Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study.

F. De Keyzer, F. Amant, R. Vanslembrouck, 2016, The British journal of radiology.

The position of neoadjuvant chemotherapy within the treatment of ovarian cancer.

P. Neven, F. Amant, T. Van Gorp, 2006, Minerva ginecologica.

CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma.

V. Abeler, F. Amant, T. van Mieghem, 2005, Gynecologic oncology.

Immunohistochemical determination of hormone receptors in uterine adenosarcomas.

F. Amant, P. Moerman, I. Vergote, 2003, Gynecologic Oncology.

UTERINE RUPTURE DUE TO 15-METHYLPROSTAGLANDIN F2α

I. Vergote, F. Uyttenbroeck, L. Oeyen, 1982, The Lancet.

Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group

T. Bourne, D. Timmerman, L. Valentin, 2000, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Dormant foci of endometrial stromal sarcoma as an intermediate between an indolent and aggressive growth

F. Amant, P. Moerman, I. Vergote, 2007 .

Bifunctional pathway of uterine carcinosarcomas.

F. Amant, I. Vergote, 2003, Human pathology.

Role of cyclin-dependent kinase p27 in uterine carcinosarcomas

F. Amant, I. Vergote, S. Caluwaerts, 2004, International Journal of Gynecologic Cancer.

The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment.

I Vergote, P. Neven, D. Lambrechts, 2010, Gynecologic oncology.

Surgical program building in advanced ovarian cancer: European perspective.

I. Vergote, P. Ottevanger, I. Vergote, 2009, Gynecologic oncology.

Wilms' Tumor Gene 1 (wt1) Overexpression in Neurons in Deep Endometriosis: a Pilot Study Article in Press

F. Amant, A. Coosemans, P. Moerman, 2022 .

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

D Timmerman, I Vergote, B De Moor, 2011, British Journal of Cancer.

Prognostic value of Ic substages in invasive epithelial ovarian carcinoma

A. Zwinderman, J. Trimbos, I. Vergote, 2014 .

ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors

T. Bourne, D. Timmerman, I. Vergote, 2021, International Journal of Gynecological Cancer.

A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: the development of a new logistic regression model.

W P Collins, D Timmerman, I Vergote, 1999, American journal of obstetrics and gynecology.

Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience

D. Timmerman, T. Bourne, W. Collins, 1999, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Wilms' tumor gene 1 immunotherapy in pelvic gynecological malignancies

I. Vergote, A. Coosemans, S. V. Van Gool, 2014, Expert review of clinical immunology.

Short-Term Prognostic Index for Breast Cancer: NPI or Lpi

S. Huffel, V. Van Belle, P. Neven, 2007, Pathology research international.

Endocrine Treatment and Prevention of Breast and Gynecological Cancers Vth International Symposium of the Flemish Gynecological Oncology Group, January 26-28, 2006.

P. Neven, I. Vergote, F. Amant, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Long-term oncological safety of minimally invasive surgery in high-risk endometrial cancer.

F. Amant, I. Vergote, C. Lok, 2016, European journal of cancer.

Classification of Sporadic and BRCA1 Ovarian Cancer Based on a Genome-Wide Study of Copy Number Variations

Bart De Moor, Olivier Gevaert, Anneleen Daemen, 2008, KES.

Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users

S. Huffel, D. Timmerman, P. Neven, 2009, Breast Cancer Research and Treatment.

Endocrine treatment and prevention of breast and gynaecological cancers.

P. Neven, W. Tjalma, I. Vergote, 2004, European journal of cancer.

IMMUNOHISTOCHEMICAL DETERMINATION OF CD10, ESTROGEN AND PROGESTERONE RECEPTOR POSITIVITY IN UTERINE ADENOSARCOMA

V. Abeler, G. Tulunay, I. Vergote, 2004, International Journal of Gynecologic Cancer.

Gynecologic Cancers in Pregnancy: Guidelines of an International Consensus Meeting

L. Lagae, J. Beijnen, F. Amant, 2009, International Journal of Gynecologic Cancer.

Wilms' tumor gene 1 (WT1) overexpression in neurons in deep endometriosis: a pilot study.

F. Amant, A. Coosemans, P. Moerman, 2009, Fertility and sterility.

Advanced epithelial ovarian cancer: 1998 consensus statements.

J. Neijt, G. Rustin, J. Berek, 1993 .

What is the role of neoadjuvant chemotherapy in advanced endometrial cancer?

F. Amant, I. Vergote, 2010, Gynecologic oncology.

Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma

P. Neven, F. Amant, B. Calster, 2007, British Journal of Cancer.

Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument

V. Abeler, E. Pettersen, C. Tropé, 2000, International Journal of Gynecologic Cancer.

Primary invasive mucinous ovarian carcinoma of the intestinal type: importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases.

K. Leunen, I. Vergote, K. Muyldermans, 2013, European Journal of Cancer.

The Role of Diaphragmatic Surgery During Interval Debulking After Neoadjuvant Chemotherapy: an Analysis of 74 Patients With Advanced Epithelial Ovarian Cancer

P. Neven, F. Amant, D. Tsolakidis, 2010, International Journal of Gynecologic Cancer.

Port‐site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma

P. Neven, I. Vergote, F. Amant, 2005, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Laparoscopy in gynaecologic oncology: a review.

I. Vergote, I. Vergote, J. Decloedt, 1999, Critical reviews in oncology/hematology.

Phase II feasibility study of sequential couplets of Cisplatin/Topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group Study.

E. Eisenhauer, A. Oza, I. Vergote, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer

I. Vergote, I. Vergote, A. Papanikolaou, 2006, Archives of Gynecology and Obstetrics.

Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.

M. Nooij, M. Namer, I. Vergote, 2001, Gynecologic oncology.